Intestinal Mucormycosis in Hemodialysis Patients Following Deferoxamine
Authors:
- Arnold R. EiserAEArnold R. Eiser
- Robert F. SlifkinRSRobert F. Slifkin
- Martin S. NeffMNMartin S. Neff
- 1 July 1987
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 10 (1) , 71-73
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Myocardial Mucormycosis With Emboli in a Hemodialysis PatientAmerican Journal of Kidney Diseases, 1986
- Listeriosis in patients with long-term hemodialysis and transfusional iron overloadThe American Journal of Medicine, 1985
- Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.BMJ, 1985
- Effects of iron and desferrioxamine on infections with Yersinia enterocoliticaInfection and Immunity, 1985
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- Microbial Iron CompoundsAnnual Review of Biochemistry, 1981
- MucormycosisAnnals of Internal Medicine, 1980
- Localization and fate of Absidia ramosa spores after intravenous inoculation of miceJournal of Comparative Pathology, 1973
- Intestinal Phycomycosis (Mucormycosis)American Journal of Clinical Pathology, 1966
- MucormycosisThe American Journal of Medicine, 1960